Upgrade to SI Premium - Free Trial

Medifast (MED) Tops Q2 EPS by 3c, Revenues Beat; Raises FY19 EPS/Revenue Guidance

August 1, 2019 5:51 PM
Medifast (NYSE: MED) reported Q2 EPS of $1.75, $0.03 better than the analyst estimate of $1.72. Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Earnings Guidance Hot Guidance Management Comments

Next Articles